FrancophonIA/ELRC3.0 huggingface dataset:
English: Treatment-naïve adult patients (400 mg twice daily) STARTMRK (multi-centre, randomised, double-blind, active-control trial) evaluated the safety and anti-retroviral activity of raltegravir 400 mg twice daily vs. efavirenz 600 mg at bedtime, in a combination with emtricitabine (+) tenofovir disoproxil fumarate, in treatment-naïve HIV-infected patients with HIV RNA > 5,000 copies/mL.
Danish: Behandlingsnaive voksne patienter (400 mg to gange dagligt) STARTMRK (randomiseret, dobbeltblindet, aktivt kontrolleret multicenterstudie) vurderede sikkerhed og antiretroviral aktivitet af raltegravir 400 mg to gange dagligt versus efavirenz 600 mg ved sengetid i en kombination med emtricitabin (+) tenofovirdisoproxilfumarat hos behandlingsnaive hiv-inficerede patienter med hiv-RNA >5.000 kopier/ml.
English: 300 mg twice daily
Danish: 300 mg to gange dagligt
English: raltegravir AUC  14% raltegravir C24hr  6% raltegravir Cmax  9%
Danish: raltegravir AUC  14% raltegravir C24t  6% raltegravir Cmax  9%
English: etravirine (raltegravir 400 mg Twice Daily)
Danish: etravirin (raltegravir 400 mg to gange dagligt)
English: Carton for the 25 mg chewable tablets
Danish: Karton til 25 mg tyggetabletter
English: If co-administration with rifampicin is unavoidable, a doubling of the dose of raltegravir can be considered (see section 4.4).
Danish: Hvis samtidig administration med rifampicin er uundgåelig, kan en dobbelt dosis raltegravir overvejes.
English: • stomach inflammation
Danish: • Leverbetændelse
English: Table 8 displays pharmacokinetic parameters in the 400 mg tablet, the chewable tablet, and the granules for oral suspension, by body weight.
Danish: Tabel 8 viser de farmakokinetiske parametre for 400 mg tabletten, tyggetabletten og granulatet til oral suspension ud fra kropsvægt.
English: The other ingredients are: hydroxypropyl cellulose, sucralose, mannitol, monoammonium glycyrrhizinate, sorbitol (E420), fructose, banana flavour, sucrose, crospovidone Type A, magnesium stearate, ethylcellulose 20 cP, ammonium hydroxide, medium chain triglycerides, oleic acid, hypromellose 2910/6cP, macrogol/PEG 400, microcrystalline cellulose and carmellose sodium.
Danish: Øvrige indholdsstoffer: hydroxypropylcellulose, sucralose, mannitol, monoammoniumglycyrrhizinat, sorbitol (E420), fructose, banansmag, sucrose, crospovidon type A, magnesiumstearat, ethylcellulose 20 cP, ammoniumhydroxid, triglycerider af middelkædelængde, oliesyre, hypromellose 2910/6cP, macrogol/PEG 400, mikrokrystallisk cellulose og carmellosenatrium.
English: No dose adjustment required for raltegravir (400 mg twice daily and 1,200 mg once daily) or tenofovir disoproxil fumarate.
Danish: Dosisjustering af raltegravir (400 mg to gange dagligt og 1.200 mg en gang dagligt) eller tenofovirdisoproxilfumarat er ikke nødvendig.
English: What Isentress looks like and contents of the pack The film-coated tablet is oval-shaped, pink, marked with "227" on one side.
Danish: Den filmovertrukne tablet er oval, lyserød, mærket "227" på den ene side.
English: raltegravir AUC ↑ 37 % raltegravir C12 hr ↑ 24 % raltegravir Cmax ↑ 51 %
Danish: raltegravir AUC ↑ 37% raltegravir C12t ↑ 24% raltegravir Cmax ↑ 51%
English: Each tablet contains 25 mg of raltegravir (as potassium).
Danish: Hver tablet indeholder 25 mg raltegravir (som kalium).
English: Percent HIV-RNA < 40 copies/mL (95 % CI)
Danish: Procent hiv-RNA < 40 kopier/ml (95 % CI)
English: Chewable tablet 100 mg - Hydroxypropyl cellulose - Sucralose - Saccharin sodium - Sodium citrate dihydrate - Mannitol - Monoammonium glycyrrhizinate - Sorbitol (E420) - Fructose - Banana flavour - Orange flavour - Masking flavour - Aspartame (E951) - Crospovidone, Type A - Sodium stearyl fumarate- Magnesium stearate - Hypromellose 2910/6cP - Macrogol/PEG 400 - Ethylcellulose 20 cP - Ammonium hydroxide - Medium chain triglycerides - Oleic acid - Red iron oxide - Yellow iron oxide
Danish: Tyggetabletter 100 mg - Hydroxypropylcellulose - Sucralose - Natriumsaccharin - Dinatriumcitrat - Mannitol - Monoammoniumglycyrrhizinat - Sorbitol (E420) - Fructose - Banansmag - Appelsinsmag - Smagsmaskering - Aspartam (E951) - Crospovidon, type A - Natriumstearylfumarat - Magnesiumstearat - Hypromellose 2910/6cP - Macrogol/PEG 400 - Ethylcellulose 20 cP - Ammoniumhydroxid - Triglycerider, middelkædelængde - Oliesyre - Rød jernoxid - Gul jernoxid
English: Table 6 displays pharmacokinetic parameters in the 400 mg tablet, the chewable tablet, and the granules for oral suspension, by body weight.
Danish: Tabel 6 viser de farmakokinetiske parametre for 400 mg tabletten , tyggetabletten og granulatet til oral suspension ud fra kropsvægt.
English: Inhibitors of UGT1A1
Danish: UGT1A1-hæmmere
English: famotidine (raltegravir 400 mg Twice Daily)
Danish: famotidin (raltegravir 400 mg to gange dagligt)
English: ISENTRESS 25 mg chewable tablets raltegravir
Danish: ISENTRESS 25 mg tyggetabletter raltegravir
English: Week 48 and Week 240 outcomes for patients on the recommended dose of raltegravir 400 mg twice daily from STARTMRK are shown in Table 5.
Danish: Resultaterne fra STARTMRK ved uge 48 og uge 240 for patienter på den anbefalede dosis raltegravir på 400 mg to gange dagligt ses i tabel 5.
English: Durable outcomes (Week 48 and Week 96) for patients on the recommended dose raltegravir 400 mg twice daily from the pooled studies BENCHMRK 1 and BENCHMRK 2 are shown in Table 4.
Danish: Holdbare resultater (uge 48 og uge 96) for patienter, der fik den anbefalede dosis raltegravir 400 mg to gange dagligt, fra de poolede studier BENCHMRK 1 og BENCHMRK 2, fremgår af tabel 4.
English: The length of combination anti-retroviral therapy, corticosteroid use, alcohol consumption, severe reduction of the activity of the immune system, higher body mass index, among others, may be some of the many risk factors for developing this disease.
Danish: Følgende kan være nogle af de mange risikofaktorer, der findes for at udvikle denne sygdom: Varigheden af den antiretrovirale kombinationsbehandling, brug af kortikosteroider, alkoholforbrug, dannelsen af antistoffer er alvorligt hæmmet (immunsuppression), højt BMI.
English: vomiting; indigestion; belching
Danish: opkastning, fordøjelsesproblemer, opstød
English: Each film-coated tablet contains 600 mg of raltegravir (as potassium).
Danish: Hver filmovertrukken tablet indeholder 600 mg raltegravir (som kalium).
English: How to store Isentress
Danish: Opbevaring af Isentress
English: Percent HIV-RNA < 50 copies/mL (95 % CI)
Danish: Procent hiv-RNA < 50 kopier/ml (95% CI)
English: No dose adjustment required for raltegravir.
Danish: Dosisjustering af raltegravir er ikke nødvendig.
English: raltegravir AUC  37 % raltegravir C12hr  28 % raltegravir Cmax  33 %
Danish: raltegravir AUC  37% raltegravir C12t  28% raltegravir Cmax  33%
English: raltegravir AUC  37% raltegravir C12hr  28% raltegravir Cmax  33%
Danish: raltegravir AUC 37% raltegravir C12t 28% raltegravir Cmax 33%
English: Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Danish: ISENTRESS filmovertrukne tabletter indeholder lactose og bør ikke anvendes til patienter med arvelig galactoseintolerans, en særlig form af arvelig lactasemangel (Lapp Lactase deficiency) eller glucose/galactose malabsorption.
English: The other ingredients are: hydroxypropyl cellulose, sucralose, saccharin sodium , sodium citrate dihydrate, mannitol, red iron oxide, yellow iron oxide, monoammonium glycyrrhizinate, sorbitol (E420), fructose, natural and artificial flavours (orange, banana, and masking), aspartame (E951), crospovidone Type A, magnesium stearate, sodium stearyl fumarate, ethylcellulose 20 cP, ammonium hydroxide, medium chain triglycerides, oleic acid, hypromellose 2910/6cP, and macrogol/PEG 400.
Danish: De øvrige indholdsstoffer er: hydroxypropylcellulose, sucralose, natriumsaccharin, dinatriumcitrat, mannitol, rød jernoxid, gul jernoxid, monoammoniumglycyrrhizinat, sorbitol (E420), fructose, naturlige og kunstige smagsvarianter (appelsin, banan og smagsmaskering), aspartam (E951), crospovidon type A, magnesiumstearat, natriumstearylfumarat, ethylcellulose 20 cP, ammoniumhydroxid, triglycerider af middelkædelængde, oliesyre, hypromellose 2910/6cP, og macrogol/PEG 400.
English: raltegravir AUC  41% raltegravir C12hr  77% raltegravir Cmax  24%
Danish: raltegravir AUC 41% raltegravir C12t 77% raltegravir Cmax 24%
English: Each film-coated tablet contains 400 mg of raltegravir (as potassium).
Danish: Hver filmovertrukken tablet indeholder 400 mg raltegravir (som kalium).
English: Autoimmune disorders (such as Graves' disease and autoimmune hepatitis) have also been reported to occur in the setting of immune reactivation: however, the reported time to onset is more variable and these events can occur many months after initiation of treatment.
Danish: Autoimmune lidelser (såsom Graves' sygdom og autoimmun hepatitis) er også rapporteret at forekomme i forbindelse med immunreaktivering.
English: The other ingredients are: hydroxypropyl cellulose, sucralose, saccharin sodium, sodium citrate dihydrate, mannitol, yellow iron oxide, monoammonium glycyrrhizinate, sorbitol (E420), fructose, natural and artificial flavours (orange, banana, and masking), aspartame (E951), crospovidone Type A, magnesium stearate, sodium stearyl fumarate, ethylcellulose 20 cP, ammonium hydroxide, medium chain triglycerides, oleic acid, hypromellose 2910/6cP and macrogol/PEG 400.
Danish: Øvrige indholdsstoffer: hydroxypropylcellulose, sucralose, natriumsaccharin, dinatriumcitrat, mannitol, gul jernoxid, monoammoniumglycyrrhizinat, sorbitol (E420), fructose, naturlige og kunstige smagsvarianter (appelsin, banan og smagsmaskering), aspartam (E951), crospovidon type A, magnesiumstearat, natriumstearylfumarat, ethylcellulose 20 cP, ammoniumhydroxid, triglycerider af middelkædelængde, oliesyre, hypromellose 2910/6cP, og macrogol/PEG 400.
English: Co-administration of raltegravir 1,200 mg once daily with calcium carbonate and aluminium/magnesium containing antacids resulted in reduced raltegravir plasma levels; therefore, co-administration is not recommended (see section 4.5).
Danish: Administration af raltegravir 1.200 mg en gang dagligt sammen med calciumcarbonat- og aluminium/magnesiumholdige antacida medførte nedsat plasmakoncentration af raltegravir.
English: Isentress is also available in a 400 mg tablet, a 600 mg tablet and in granules for oral suspension.
Danish: Isentress fås også som en 400 mg tablet, en 600 mg tablet og som granulat til oral suspension.
English: Percent HIV-RNA < 50 copies/mL (95 % CI) All patients Baseline Characteristic HIV-RNA > 100,000 copies/mL ≤ 100,000 copies/mL CD4-count ≤ 50 cells/mm > 50 and ≤ 200 cells/mm > 200 cells/mm Viral Subtype Clade B Non-Clade B
Danish: Procent hiv-RNA < 50 kopier/ml (95% CI) Alle patienter Karakteristika ved baseline Hiv-RNA > 100.000 kopier/ml ≤ 100.000 kopier/ml CD4-celletal ≤ 50 celler/mm > 50 og ≤ 200 celler/mm > 200 celler/mm Virusundertype Clade B Non-Clade B
English: No dose adjustment required for raltegravir (400 mg twice daily and 1,200 mg once daily) or maraviroc.
Danish: Dosisjustering af raltegravir (400 mg to gange dagligt og 1.200 mg en gang dagligt) eller maraviroc er ikke nødvendig.
English: raltegravir AUC  4% raltegravir C12hr  25% raltegravir Cmax  11%
Danish: raltegravir AUC  4% raltegravir C12t  25% raltegravir Cmax  11%
English: If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Danish: Er du i tvivl, så spørg dit barns læge, apotekspersonalet eller sundhedspersonalet.
English: Do not switch between the chewable tablet, granules for oral suspension, 600 mg tablet or 400 mg tablet without first talking with your doctor, pharmacist or nurse.
Danish: Skift ikke mellem tyggetabletten, granulatet til oral suspension, 600 mg tabletten eller 400 mg tabletten uden først at tale med lægen, apotekspersonalet eller sundhedspersonalet.
English: Do not switch between the 600 mg tablet, 400 mg tablet, chewable tablet or granules for oral suspension without first talking with your doctor, pharmacist or nurse.
Danish: Skift ikke mellem 600 mg tabletten, 400 mg tabletten, tyggetabletten eller granulatet til oral suspension uden først at tale med lægen, apotekspersonalet eller sundhedspersonalet.
English: Do not switch between the 400 mg tablet, the 600 mg tablet, chewable tablet or granules for oral suspension without first talking with your doctor, pharmacist or nurse.
Danish: Skift ikke mellem 400 mg tabletten, 600 mg tabletten, tyggetabletten eller granulatet til oral suspension uden først at tale med lægen, apotekspersonalet eller sundhedspersonalet.
English: • inflammation of liver
Danish: • Betændelse i mavens slimhinde
English: Patients can remain on the oral suspension as long as their weight is below 20 kg.
Danish: Patienterne kan anvende den orale suspension så længe deres vægt ligger under 20 kg. Se tabel 2 for relevant dosering (se pkt.
English: Mean CD4 Cell Change (95 % CI), cells/mm All patients Baseline Characteristic HIV-RNA > 100,000 copies/mL ≤ 100,000 copies/mL CD4-count ≤ 50 cells/mm > 50 and ≤ 200 cells/mm > 200 cells/mm Sensitivity score (GSS)
Danish: Gennemsnitlig ændring i CD4-celletal (95% CI), celler/mm Alle patienter Karakteristika ved baseline Hiv-RNA > 100.000 kopier/ml ≤ 100.000 kopier/ml CD4-celletal ≤ 50 celler/mm > 50 og ≤ 200 celler/mm > 200 celler/mm Sensitivitets-score (GSS)
English: raltegravir AUC  24 % raltegravir C12hr  55 % raltegravir Cmax  18 %
Danish: raltegravir AUC 24% raltegravir C12t 55% raltegravir Cmax 18%
English: raltegravir AUC  40% raltegravir C12hr  61% raltegravir Cmax  38%
Danish: raltegravir AUC  40% raltegravir C12t  61% raltegravir Cmax  38%
English: raltegravir AUC  40 % raltegravir C12hr  61 % raltegravir Cmax  38 %
Danish: raltegravir AUC 40% raltegravir C12t 61% raltegravir Cmax 38%
English: ISENTRESS 100 mg chewable tablets
Danish: ISENTRESS 100 mg tyggetabletter
English: No dose adjustment required for raltegravir (400 mg twice daily and 1,200 mg once daily) or boceprevir.
Danish: Dosisjustering af raltegravir (400 mg to gange dagligt og 1.200 mg en gang dagligt) eller boceprevir er ikke nødvendig.
English: No dose adjustment required for raltegravir (400 mg twice daily and 1,200 mg once daily).
Danish: Dosisjustering af raltegravir (400 mg to gange dagligt og 1.200 mg en gang dagligt) er ikke nødvendig.
English: raltegravir AUC  36 % raltegravir C12hr  21 % raltegravir Cmax  36 %
Danish: raltegravir AUC  36% raltegravir C12t  21% raltegravir Cmax  36%
English: raltegravir AUC  36% raltegravir C12hr  21% raltegravir Cmax  36%
Danish: raltegravir AUC 36% raltegravir C12t 21% raltegravir Cmax 36%
English: 2 hours before raltegravir raltegravir AUC  51 % raltegravir C12 hr  56 % raltegravir Cmax  51 %
Danish: 2 timer før raltegravir raltegravir AUC  51% raltegravir C12t  56% raltegravir Cmax  51%
English: Baseline Characteristic HIV-RNA > 100,000 copies/mL ≤ 100,000 copies/mL CD4-count ≤ 50 cells/mm > 50 and ≤ 200 cells/mm > 200 cells/mm Viral Subtype Clade B Non-Clade B
Danish: Hiv-RNA > 100.000 kopier/ml ≤ 100.000 kopier/ml CD4-celletal ≤ 50 celler/mm > 50 og ≤ 200 celler/mm > 200 celler/mm Virusundertype Clade B Non-Clade B
English: ISENTRESS is also available in a 400 mg tablet and as granules for oral suspension for use.
Danish: ISENTRESS fås også som en 400 mg tablet og som granulat til oral suspension.
English: 12 hours after raltegravir raltegravir AUC  10% raltegravir C24 hr  57% raltegravir Cmax  2%
Danish: 12 timer efter raltegravir raltegravir AUC  10% raltegravir C24t  57% raltegravir Cmax  2%
English: Do not switch between the granules for oral suspension, chewable tablet, 600 mg tablet or 400 mg tablet without first talking to your child's doctor, pharmacist or nurse.
Danish: Skift ikke mellem granulatet til oral suspension, tyggetabletten, 600 mg tabletten eller 400 mg tabletten uden først at tale med lægen, apotekspersonalet eller sundhedspersonalet.
English: raltegravir AUC  10 % raltegravir C12hr  34 % raltegravir Cmax  11 %
Danish: raltegravir AUC  10% raltegravir C12t  34% raltegravir Cmax  11%
English: raltegravir AUC  10% raltegravir C12hr  34% raltegravir Cmax  11%
Danish: raltegravir AUC 10% raltegravir C12t 34% raltegravir Cmax 11%
English: Measure Isentress
Danish: Trin 10. Afmål Isentress
English: Each tablet contains 600 mg of raltegravir (as potassium).
Danish: Hver tablet indeholder 600 mg raltegravir (som kalium).
English: Co-administration of raltegravir 1,200 mg once daily with tipranavir/ritonavir could result in decreased raltegravir trough plasma levels; therefore, co-administration is not recommended (see section 4.5).
Danish: Administration af raltegravir 1.200 mg en gang dagligt sammen med tipranavir/ritonavir kan medføre nedsat dalkoncentration af raltegravir i plasma.
English: 6 hours after raltegravir raltegravir AUC  11 % raltegravir C12 hr  49 % raltegravir Cmax  10 %
Danish: 6 timer efter raltegravir raltegravir AUC  11% raltegravir C12t  49% raltegravir Cmax  10%
English: No dosage adjustment required for raltegravir (400 mg twice daily and 1,200 mg once daily) or midazolam.
Danish: Dosisjustering af raltegravir (400 mg to gange dagligt og 1.200 mg en gang dagligt) eller midazolam er ikke nødvendig.
English: Each tablet contains 400 mg of raltegravir (as potassium).
Danish: Hver tablet indeholder 400 mg raltegravir (som kalium).
English: Percent HIV-RNA < 400 copies/mL (95 % CI) All patients Baseline Characteristic HIV-RNA > 100,000 copies/mL ≤ 100,000 copies/mL CD4-count ≤ 50 cells/mm > 50 and ≤ 200 cells/mm > 200 cells/mm Sensitivity score (GSS)
Danish: Procent hiv-RNA < 400 kopier/ml (95% CI) Alle patienter Karakteristika ved baseline Hiv-RNA > 100.000 kopier/ml ≤ 100.000 kopier/ml CD4-celletal ≤ 50 celler/mm > 50 og ≤ 200 celler/mm > 200 celler/mm Sensitivitets-score (GSS)
English: 6 hours before raltegravir raltegravir AUC  13 % raltegravir C12 hr  50 % raltegravir Cmax  10 %
Danish: 6 timer før raltegravir raltegravir AUC  13% raltegravir C12t  50% raltegravir Cmax  10%
English: raltegravir AUC ↑ 44 % raltegravir C12 hr ↑ 6 % raltegravir Cmax ↑ 60 %
Danish: raltegravir AUC ↑ 44% raltegravir C12t ↑ 6% raltegravir Cmax ↑ 60%
English: Uncommon arthralgia, arthritis, back pain, flank pain, musculoskeletal pain, myalgia, neck pain, osteopenia, pain in extremity, tendonitis, rhabdomyolysis
Danish: Ikke almindelig Artralgi, artrit, rygsmerter, lændesmerter, smerter i knogler, led og muskler, myalgi, nakkesmerter, osteopeni, smerter i ekstremiteterne, tendinitis, rabdomyolyse
English: aluminium/magnesium hydroxide antacid (raltegravir 1,200 mg single dose)
Danish: Anbefalinger vedrørende samtidig administration antacidum med aluminium- og magnesiumhydroxid (raltegravir 1.200 mg enkeltdosis)
English: ISENTRESS 400 mg film-coated tablets
Danish: ISENTRESS 400 mg filmovertrukne tabletter.
English: raltegravir AUC  55 % raltegravir C12 hr  32 % raltegravir Cmax  52 %
Danish: raltegravir AUC  55% raltegravir C12t  32% raltegravir Cmax  52%
English: Uncommon asthenia, fatigue, pyrexia chest discomfort, chills, face oedema, fat tissue increased, feeling jittery, malaise, submandibular mass, oedema peripheral, pain
Danish: Gener i brystet, kuldegysninger, ansigtsødem, øget fedtvæv, anspændthed, utilpashed, submandibulær hævelse, perifere ødemer, smerter
English: No dose adjustment required for raltegravir (400 mg twice daily and 1,200 mg once daily) or methadone.
Danish: Dosisjustering af raltegravir (400 mg to gange dagligt eller 1.200 mg en gang dagligt) eller methadon er ikke nødvendig.
English: No dose adjustment required for raltegravir (400 mg twice daily).
Danish: Dosisjustering af raltegravir (400 mg to gange dagligt) er ikke nødvendig.
English: No dose adjustment required for raltegravir (400 mg twice daily and 1,200 mg once daily) or etravirine.
Danish: Dosisjustering af raltegravir (400 mg to gange dagligt og 1.200 mg en gang dagligt) eller etravirin er ikke nødvendig.
English: 2 hours after raltegravir raltegravir AUC  30% raltegravir C12 hr  57% raltegravir Cmax  24%
Danish: 2 timer efter raltegravir raltegravir AUC  30% raltegravir C12t  57% raltegravir Cmax  24%
English: Adults, children and adolescents weighing at least 40 kg The recommended dose is 1,200 mg taken as two 600 mg tablets taken by mouth once a day.
Danish: Den anbefalede dosis er 1.200 mg, der skal tages som to 600 mg tabletter gennem munden en gang om dagen.
English: Each tablet contains 100 mg of raltegravir (as potassium).
Danish: Hver tablet indeholder 100 mg raltegravir (som kalium).
English: 2 hours after raltegravir raltegravir AUC  30 % raltegravir C12 hr  57 % raltegravir Cmax  24 %
Danish: 2 timer efter raltegravir raltegravir AUC  30% raltegravir C12 t  57% raltegravir Cmax  24%
English: Baseline Characteristic HIV-RNA > 100,000 copies/mL ≤ 100,000 copies/mL CD4-count ≤ 50 cells/mm
Danish: Karakteristika ved baseline Hiv-RNA > 100.000 kopier/ml ≤ 100.000 kopier/ml CD4-celletal ≤ 50 celler/mm > 50 og ≤ 200 celler/mm
English: raltegravir AUC  49 % raltegravir C12hr  3 % raltegravir Cmax ↑ 64 %
Danish: raltegravir AUC 49% raltegravir C12t 3% raltegravir Cmax ↑64%
English: Baseline Characteristic HIV-RNA > 100,000 copies/mL 196 (174, 219) 192 (169, 214) ≤ 100,000 copies/mL 180 (160, 200) 134 (115, 153) CD4-count ≤ 50 cells/mm > 50 and ≤ 200 cells/mm > 200 cells/mm Viral Subtype Clade B Non-Clade B
Danish: Karakteristika ved baseline Hiv-RNA > 100,000 kopier/ml 276 (245; 308) ≤ 100,000 kopier/ml 214 (194; 235) CD4-celletal ≤ 200 celler/mm > 200 celler/mm Virusundertype Clade B Non-Clade B 233 (205; 261)
English: 8 mL (80 mg) twice daily 3 x 25 mg twice daily
Danish: 3 x 25 mg to gange dagligt
English: • allergic rash
Danish: • Allergisk udslæt
English: Baseline Characteristic HIV-RNA > 100,000 copies/mL ≤ 100,000 copies/mL CD4-count ≤ 50 cells/mm > 50 and ≤ 200 cells/mm > 200 cells/mm Sensitivity score (GSS)
Danish: Alle patienter Karakteristika ved baseline Hiv-RNA > 100.000 kopier/ml ≤ 100.000 kopier/ml CD4-celletal ≤ 50 celler/mm > 50 og ≤ 200 celler/mm > 200 celler/mm Sensitivitets-score (GSS)
English: Isentress is also available in a 600 mg tablet, a chewable tablet and in granules for oral suspension.
Danish: Isentress fås også som en 600 mg tablet, en tyggetablet og som granulat til oral suspension.
English: Refer to the chewable tablet SmPC for additional dosing information.
Danish: Se produktresuméet for tyggetabletten for yderligere oplysninger om dosering.
English: Based on these data, proton pump inhibitors and H2 blockers may be co-administered with raltegravir 1,200 mg once daily.
Danish: Der blev opnået sammenlignelige resultater for virkning og sikkerhed både med og uden disse lægemidler, der ændrer gastrisk pH. På basis af disse data kan protonpumpehæmmere og H2-blokkere administreres sammen med raltegravir 1.200 mg en gang dagligt.
English: ISENTRESS 100 mg chewable tablets raltegravir
Danish: ISENTRESS 100 mg tyggetabletter raltegravir
English: Tabulated summary of adverse reactions
Danish: klasse NNRTI PI Respons
English: ISENTRESS 400 mg film-coated tablets raltegravir
Danish: Isentress 400 mg filmovertrukne tabletter raltegravir
English: Isentress 600 mg film-coated tablets raltegravir
Danish: ISENTRESS 600 mg filmovertrukne tabletter raltegravir
English: ISENTRESS 600 mg film-coated tablets raltegravir
Danish: Isentress 600 mg filmovertrukne tabletter raltegravir
English: Elderly
Danish: baseline
English: Each sachet contains 100 mg of raltegravir (as potassium).
Danish: Hver foliepose indeholder 100 mg raltegravir (som kalium).
English: Baseline Characteristic HIV-RNA > 100,000 copies/mL 196 (174, 219) ≤ 100,000 copies/mL 180 (160, 200) CD4-count ≤ 50 cells/mm > 50 and ≤ 200 cells/mm > 200 cells/mm Viral Subtype Clade B Non-Clade B
Danish: Alle patienter Karakteristika ved baseline Hiv-RNA > 100.000 kopier/ml ≤ 100.000 kopier/ml CD4-celletal ≤ 50 celler/mm > 50 og ≤ 200 celler/mm > 200 celler/mm Virusundertype Clade B Non-Clade B 189 (153; 225)